TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Straumann Holding AG ( (CH:STMN) ) is now available.
Straumann Holding AG reported strong half-year results with sales reaching CHF 1.3 billion, reflecting a 10.2% organic growth. Despite challenges like unfavorable currency developments, the company maintained a robust core EBIT margin and confirmed its 2025 outlook. Key product launches, including the iEXCEL implant system and MIDAS 3D printer, have gained momentum, supporting Straumann’s strategic focus on digital transformation and capacity expansion. The company’s broad-based growth across all regions and business segments underscores its strong market positioning and commitment to innovation.
The most recent analyst rating on (CH:STMN) stock is a Hold with a CHF143.00 price target. To see the full list of analyst forecasts on Straumann Holding AG stock, see the CH:STMN Stock Forecast page.
More about Straumann Holding AG
Straumann Holding AG operates in the dental industry, focusing on premium implantology, digital solutions, and orthodontics. The company is known for its innovative products like the iEXCEL implant system and the MIDAS 3D printer, aiming to build a comprehensive digital ecosystem for dental experts worldwide.
Average Trading Volume: 286,340
Technical Sentiment Signal: Sell
Current Market Cap: CHF16.02B
Learn more about STMN stock on TipRanks’ Stock Analysis page.